# K180198: NuVasive® VuePoint® II OCT System

- Pathway: 510(k) (Traditional)
- Applicant: Nu Vasive, Incorporated
- Decided: Mar 15, 2018 after 50 days
- Product code: NKG (Posterior Cervical Screw System)
- Device class: 2
- Regulation: 21 CFR 888.3075
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 18 generations back to K040583 (2004). 328 ancestors in all.
4 later devices descend from it; 3 cite it directly.
1 of 333 devices in its family (counting itself) has a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K150474: NuVasive VuePoint II OCT System, Nu Vasive, Incorporated (2015) Summary page 4.
- K093319: Nuvasive Vuepoint Oct System, Nuvasive, Inc. (2010) Summary page 4.
- K142838: Synapse Occipital-Cervical-Thoracic (OCT) System, Synthes USA Products, LLC (2015) Summary page 4.
- K161014: NuVasive® Reline® System, Nu Vasive, Incorporated (2016) Summary page 4.

## Most influential descendants
- K191553: NuVaisve® Reline® Cervical System (2019), 2 descendants of its own
- K213654: NuVasive Reline Cervical System (2022), 1 descendant of its own
- K221388: NuVasive Reline Cervical System (2022), 0 descendants of its own
- K211993: Z-LINKPC System (2021), 0 descendants of its own

## Indications for use
The NuVasive® VuePoint® II OCT System is intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion for the following acute and chronic instabilities of the craniocervical junction, the cervical spine (C1 to C7) and the thoracic spine (T1-T3): traumatic spinal fractures and/or traumatic dislocations; instability or deformity; failed previous fusions (e.g., pseudoarthrosis); tumors involving the cervical spine; and degenerative disease, including intractable radiculopathy and/or myelopathy, neck and/or arm pain of discogenic origin as confirmed by radiographic studies, and degenerative disease of the facets with instability. The VuePoint II OCT System is also intended to restore the integrity of the spinal column even in the absence of fusion for a limited time period in patients with advanced stage tumors involving the cervical spine in whom life expectancy is of insufficient duration to permit achievement of fusion. In order to achieve additional levels of fixation, the VuePoint II OCT System may be connected to the NuVasive® SpheRx® Spinal System, Precept® Spinal System, Armada® Spinal System, Reline®System and Reline® 4.5-5.0 System via the rod to rod connectors or transition rods.

Source page: https://510kreport.com/device/K180198
Methodology: https://510kreport.com/methodology